Plus   Neg

Stock Alert: Zynex Slips 10%

Shares of medical technology company Zynex, Inc. (ZYXI) are falling more than 10% Wednesday morning at $23.13. It has traded in the range of $7.12- $29.73.

Tuesday, the company has priced its previously-announced 2.5 million stock offering at $22 per share for gross proceeds of about $27.5 million.

The company plans to use the net proceeds to expand its sales force and marketing activities, launching its blood volume monitor, and for other general purposes.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT